pancreat
diseas
associ
primari
endocrin
condit
sever
anim
speci
uncommonli
identifi
hors
possibl
due
nonspecif
clinic
sign
lack
specif
biochem
marker
object
prospect
studi
assess
whether
plasmat
dggrlipas
activ
could
detect
pancreat
diseas
secondari
equin
endocrin
condit
fifti
four
case
present
two
endocrin
diseas
ppid
n
em
n
andor
hypertriglyceridaemia
n
healthi
control
hors
includ
result
compar
use
mann
whitney
test
level
signific
set
refer
rang
plasmat
dggrlipas
activ
control
group
ul
median
plasmat
dggrlipas
activ
ppid
ul
hypertriglyceridaem
hors
respect
nine
hors
increas
activ
dggrlipas
ul
concurr
present
digest
condit
lipas
activ
statist
differ
diseas
hors
control
hypertriglyceridaem
hors
compar
control
ppid
hors
versu
control
diseas
hors
digest
sign
compar
diseas
hors
without
digest
sign
exclud
case
also
affect
digest
condit
n
plasmat
lipas
concentr
still
significantli
higher
within
refer
rang
diseas
hors
compar
control
pancreat
diseas
may
signific
studi
popul
studi
larger
number
case
warrant
assess
reliabl
plasmaticlipas
activ
confirm
andor
rule
pancreat
associ
primari
endocrin
diseas
object
describ
physicochem
paramet
diarrheic
hors
appar
normal
acidbas
state
base
normal
venou
ph
pco
base
excess
determin
preval
mix
metabol
acidbas
ab
disord
patient
method
complet
computer
heparin
venou
blood
gase
electrolyt
total
protein
tp
gl
diarrheic
hors
normal
ph
pco
mmhg
base
excess
mml
record
ab
disord
hors
defin
variabl
outsid
follow
refer
rang
base
excess
mml
hco
mml
ag
mml
strong
ion
differ
sid
na
k
cl
llactat
mml
total
concentr
nonvolatil
buffer
tot
tp
gl
mml
unmeasur
strong
anion
usa
tot
sid
hco
mml
result
hors
includ
sid
ab
disord
singl
metabol
ab
disord
identifi
diarrheic
hors
includ
strong
ion
acidosi
usa
acidosi
detect
mix
metabol
ab
disord
sid
acidosi
tot
alkalosi
usa
acidosi
tot
alkalosi
discuss
hidden
mix
metabol
ab
disord
hors
character
acidifi
effect
low
sid
concurr
alkalin
effect
hypoproteinemia
hypoproteinem
alkalosi
low
sid
acidosi
classic
concurr
seen
diarrheic
hors
conclus
physicochem
approach
detect
underli
mix
metabol
disord
hors
appar
normal
ab
balanc
signific
addit
venou
ph
pco
hco
clinician
use
physicochem
approach
identifi
hidden
ab
disord
diarrheic
hors
key
word
bicarbon
ph
physicochem
approach
sid
strong
ion
method
faecal
sampl
two
group
adult
hors
foal
donkey
test
equin
coronaviru
rna
use
quantit
pcr
group
one
consist
faecal
sampl
submit
vet
request
ecov
test
second
group
compris
faecal
sampl
hors
clinic
suspicion
ecov
infect
n
protein
gene
one
posit
case
sequenc
result
equin
coronaviru
detect
sampl
three
yearl
one
adult
hors
group
one
faecal
sampl
test
qpcrneg
three
thoroughbr
yearl
premis
diagnos
success
treat
concurr
larval
cyathostomiasi
adult
hors
cob
differ
premis
present
inappet
lethargi
pyrexia
leucopaenia
made
full
recoveri
support
care
partial
sequenc
viral
rna
adult
hors
show
homolog
previous
report
ecov
strain
usa
japan
discuss
ecov
detect
small
number
hors
clinic
suspicion
diseas
clinic
sign
adult
hors
similar
report
case
countri
three
younger
hors
coronaviru
may
play
role
coinfect
incident
find
conclus
first
report
molecular
detect
ecov
hors
uk
signific
ecov
present
uk
consid
potenti
pathogen
magnesium
use
food
supplement
human
diabet
patient
may
benefici
hors
insulin
resist
well
far
magnesium
supplement
mgkg
routin
use
high
perform
hors
doseeffect
relat
determin
therefor
studi
magnesium
concentr
blood
lymphocyt
serum
urin
fraction
excret
urin
measur
five
hors
oral
supplement
seven
day
mgkg
magnesium
magnesiumaspartatehydrochlorid
mah
hors
exclus
fed
hay
magnesium
concentr
measur
week
hors
examin
daili
includ
sign
colic
soft
fece
signific
chang
magnesium
concentr
diet
sign
colic
soft
fece
side
effect
observ
serum
magnesium
concentr
supplement
mgkg
magnesium
mah
significantli
higher
baselin
wilcoxon
signedrank
test
exceed
refer
rang
four
five
hors
mgkg
magnesium
mah
serum
magnesium
concentr
show
signific
increas
time
friedman
test
neither
signific
increas
intracellular
magnesium
concentr
signific
chang
urin
magnesium
concentr
fraction
excret
observ
dosag
mgkg
magnesium
mah
requir
longer
supplement
observ
period
seem
far
effect
rais
serum
magnesium
concentr
safe
use
mgkg
magnesium
mah
could
lead
side
effect
longterm
supplement
key
word
food
supplement
magnesiumaspartatehydrochlorid
magnesium
supplement
object
studi
valid
use
acoust
ecg
monitor
audicorv
r
healthi
hors
devic
provid
inexpens
noninvas
examinerindepend
method
combin
holter
ecg
phonocardiogram
record
ecg
variabl
indic
mechan
activ
hemodynam
heart
aim
establish
devic
usabl
testretest
reliabl
normal
refer
interv
snapshot
overnight
record
obtain
healthi
warmblood
follow
variabl
measur
electromechan
activ
time
emat
ms
ratecorrect
ematc
left
ventricular
systol
time
lvst
ms
ratecorrect
lvstc
intens
persist
third
fourth
heart
sound
qr
durat
ratecorrect
qtc
interv
associ
age
sex
investig
triplic
record
hors
use
assess
testretest
variabl
audicorv
r
record
feasibl
hors
refer
interv
calcul
age
sex
significantli
influenc
variabl
testretest
variabl
low
low
cv
overnight
record
vari
low
high
snapshot
cv
conclus
studi
show
overnight
audicorv
r
record
feasibl
provid
potenti
use
indic
cardiac
perform
snapshot
repres
pointofcar
applic
method
highli
variabl
may
limit
clinic
valu
wherea
hour
overnight
record
provid
reliabl
data
futur
studi
need
focu
hors
heart
diseas
establish
clinic
valu
audicorv
r
method
assess
cardiac
perform
diagnos
cardiac
diseas
object
examin
possibl
associ
outbreak
liver
diseas
presenc
mycotoxin
forag
method
forag
sampl
subject
analysi
differ
mycotoxin
forag
sourc
either
case
premis
least
hors
confirm
suffer
hepat
diseas
base
increas
hepat
enzym
andor
liver
biopsi
control
premis
least
hors
subject
blood
test
reveal
increas
hepat
enzym
result
forag
sampl
analys
case
premis
control
premis
mycotoxin
found
case
sampl
control
sampl
mycotoxin
found
case
control
sampl
compris
singl
case
aflatoxin
aflatoxin
methylergonovin
verruculogen
wortmannin
zearalenon
nivalenol
case
acdon
deoxynivalenol
case
fumonisin
aflatoxin
found
case
control
sampl
discuss
previou
public
associ
hepat
diseas
aflatoxin
fumonisin
consumpt
studi
clear
associ
aflatoxin
contamin
forag
liver
diseas
fumonisin
seen
case
premis
microgkg
forag
conclus
examin
hay
sampl
case
control
premis
rais
suspicion
fumonisin
possibl
caus
outbreak
hepatopathi
signific
chang
forag
even
mycotoxin
adsorb
might
help
manag
outbreak
hepat
diseas
hors
key
word
liver
outbreak
forag
mycotoxin
object
recent
equin
hepaciviru
eqhv
identifi
donkey
serum
sampl
object
prove
equin
hepaciviru
harvest
infect
hors
serum
abl
infect
adult
donkey
character
cours
infect
method
prospect
studi
two
adult
femal
donkey
one
control
hors
inocul
intraven
purifi
eqhv
natur
infect
hors
anim
underw
daili
clinic
examin
blood
drawn
weekli
interv
week
haematolog
data
gldh
ggt
ast
fibrinogen
evalu
serum
antibodi
analys
luciferas
immunoprecipit
assay
viral
load
quantifi
use
realtim
pcr
liver
biopsi
taken
inocul
eqhv
pcr
posit
serum
result
anim
eqhv
pcr
posit
day
post
inocul
maxim
viral
load
ml
donkey
clear
viru
blood
week
antibodi
eqhv
detect
anim
week
respect
week
hors
donkey
histopatholog
signific
differ
observ
liver
tissu
one
two
week
infect
infect
impact
clinic
find
anim
blood
biochemistri
reveal
mild
increas
gldh
time
seroconvers
donkey
discuss
conclus
signific
eqhv
capabl
infect
distinct
host
within
genu
equu
two
donkey
studi
cours
infect
similar
infect
pattern
observ
hors
object
neg
acut
phase
protein
alreadi
use
human
veterinari
medicin
mainli
produc
liver
recent
paraoxonbas
method
measur
hors
valid
refer
interv
ri
healthi
hors
foal
establish
uml
speci
activ
low
newborn
inform
activ
newborn
foal
often
affect
inflammatori
condit
avail
therefor
aim
studi
evalu
activ
newborn
healthi
foal
verifi
age
relat
variat
method
aim
measur
serum
collect
healthi
foal
day
alreadi
valid
paraoxonbas
method
result
activ
low
birth
uml
increas
day
uml
day
uml
day
uml
day
uml
day
uml
signific
differ
p
among
age
group
discuss
result
confirm
activ
low
first
day
life
increas
age
conclus
inform
import
overdiagnos
sepsi
newborn
base
low
activ
compar
refer
interv
adult
foal
signific
next
step
establish
refer
interv
first
day
life
evalu
activ
foal
sepsi
order
assess
whether
may
use
diagnost
marker
sepsi
key
word
age
newborn
foal
serum
object
examin
diagnost
valu
novel
qpcr
assay
design
detect
equin
dermatophyt
infect
method
qpcr
assay
design
detect
target
within
chitin
sythetas
betatubulin
gene
consid
specif
dermatophyt
speci
includ
known
affect
equid
assay
use
store
frozen
hairskin
sampl
previous
subject
cultur
use
saboraud
agar
sab
also
prospect
freshli
submit
sampl
hairskin
also
subject
cultur
sab
six
differ
dna
extract
method
use
time
result
total
sampl
store
fresh
examin
sampl
singl
pcrsampl
store
sampl
insuffici
sampl
remain
reexamin
subsequ
improv
extract
method
sampl
sampl
neg
cultur
pcr
clinic
specimen
hors
sign
skin
diseas
discuss
compar
cultur
pcr
found
sensit
least
pcr
appli
normal
hair
reveal
specif
compar
pcr
cultur
sab
sensit
conclus
qpcr
assay
found
high
sensit
specif
dermatophytosi
hors
cultur
sab
may
fail
identifi
approxim
dermatophytosi
case
dna
extract
method
found
crucial
step
signific
qpcr
assay
offer
rapid
accur
mean
identifi
dermatophyt
infect
hors
object
recent
studi
shown
diagnost
valu
mirna
fingerprint
whole
blood
human
patient
cancer
studi
investig
use
whole
blood
mirna
prognost
biomark
monitor
diseas
dynam
equin
sarcoid
es
affect
hors
method
hors
spontan
regress
hors
progress
es
diseas
control
hors
includ
longitudin
studi
whole
blood
sampl
taken
initi
present
use
input
materi
high
throughput
sequenc
illumina
clinic
outcom
reevalu
year
result
differenti
express
mirna
account
control
condit
identifi
adjust
pvalu
fold
chang
either
direct
regress
vs
progress
group
mirna
upregul
mirna
downregul
whole
blood
hors
regress
es
diseas
discuss
mirna
deregul
seem
associ
phenotyp
aggress
es
diseas
direct
target
downregul
gene
top
sarcoma
biomarkerdiseas
associ
accord
genego
diseas
ontolog
metacor
tm
softwar
suit
direct
target
upregul
gene
show
enrich
network
process
like
cell
dna
damagecor
dna
damagemmr
repair
conclus
whole
blood
mirna
fingerprint
may
allow
predict
prognosi
esaffect
hors
signific
noninvas
prognost
biomark
es
diseas
might
promis
prepurchas
exam
esaffect
hors
decisionmak
whether
treatment
initi
key
word
biomark
equin
oncolog
equin
sarcoid
microrna
object
character
faecal
microbiota
hors
atyp
myopathi
compar
healthi
cograz
hcg
method
fresh
faecal
sampl
obtain
hors
stallion
geld
femal
mean
age
year
confirm
hcg
geld
femal
mean
age
year
outbreak
belgium
bacteri
taxonomi
profil
obtain
amplicon
sequenc
faec
use
identifi
differenti
distribut
bacteri
taxa
hcg
result
statist
compar
use
welch
ttest
stamp
softwar
result
total
sequenc
analys
cluster
oper
taxonom
unit
bacteri
popul
distribut
phyla
although
sequenc
could
attribut
exist
phylum
hors
harbour
significantli
higher
rel
abund
ruminococcaea
famili
significantli
lower
lachnospiracea
compar
hcg
discuss
caus
hypoglycin
intox
part
hors
pastur
toxic
environ
develop
patholog
suggest
may
protect
factor
hors
level
result
studi
show
signific
differ
faecal
microbiota
case
hcg
could
suggest
microbiota
could
play
role
develop
prevent
clinic
diseas
conclus
result
demonstr
microbiota
affect
hors
significantli
differ
compar
hcg
signific
microbiom
could
influenc
develop
role
deserv
investig
bronchoalveolar
lavag
method
recoveri
respiratori
secret
lower
airway
alveoli
use
primarili
cytolog
evalu
nonsept
condit
especi
help
sever
equin
asthma
mild
equin
asthma
exercis
induc
pulmonari
hemorrhag
eiph
suspect
clinician
observ
endoscopi
hors
sampl
bronchu
collaps
vacuum
appli
retriev
bal
fluid
therebi
reduc
amount
recov
fluid
poor
bronchoalveolar
lavag
fluid
balf
recoveri
observ
hors
moder
sever
inflamm
object
studi
investig
administr
singl
dose
bronchodil
equin
patient
suspicion
sever
equin
asthma
could
help
improv
recoveri
balf
total
hors
sever
equin
asthma
evalu
hors
pretreat
minut
bal
mgkg
inhal
salbutamol
hors
treat
bronchoalveolar
lavag
perform
balcathet
instil
ml
warm
steril
salin
use
ml
syring
amount
recov
fluid
record
statist
analysi
perform
twotail
student
ttest
use
excel
mean
balf
recoveri
treat
group
nottreat
group
p
conclud
singl
pretreat
salbutamol
hors
sever
equin
asthma
improv
volum
recov
fluid
bal
therefor
clinician
consid
procedur
perform
bal
hors
suspicion
bronchoconstrict
strangl
caus
bacteria
streptococcu
equi
subsp
equi
equi
highli
contagi
diseas
numer
outbreak
everi
year
question
remain
outbreak
optim
durat
quarantin
stabl
materi
clean
disinfect
ideal
situat
purpos
studi
obtain
knowledg
equi
surviv
variou
materi
identifi
effici
method
disinfect
contamin
equip
studi
divid
two
part
first
stabl
equip
contamin
equi
sampl
obtain
interv
use
differ
clean
protocol
second
part
stabl
strangl
outbreak
sampl
obtain
environ
approxim
three
week
hors
clinic
healthi
analys
equi
cultur
qpcr
result
show
equi
surviv
three
week
fill
water
bucket
indoor
die
within
four
day
wooden
post
outdoor
summer
weather
contamin
plastic
twitch
need
rigor
disinfect
ensur
neg
result
cultur
qpcr
result
stabl
show
bacteria
exist
hors
environ
even
week
clinic
healthi
result
confirm
equi
surviv
substanti
time
outsid
host
anim
indirect
rout
therefor
import
role
infect
find
studi
help
decreas
number
futur
outbreak
key
word
strangl
contamin
twitch
wooden
post
reason
perform
studi
endoscop
examin
essenti
diagnost
treatment
strangl
equi
infect
hors
howev
practition
often
reluct
use
endoscop
purpos
due
concern
even
clean
disinfect
endoscop
may
retain
live
equi
bacteria
bacteri
dna
object
studi
evalu
efficaci
four
differ
disinfect
method
elimin
equi
videoendoscop
method
videoendoscop
contamin
standard
equi
broth
solut
disinfect
follow
four
differ
protocol
three
field
situat
protocol
use
variou
disinfect
manual
clean
group
ethanol
group
b
didecyldimethylammoniumchlorid
group
c
isopropyl
alcohol
enzymebas
solut
disinfect
orthophtaldehyd
group
use
commerci
endoscop
wash
machin
geting
protocol
ml
distil
water
flush
endoscop
biopsi
channel
analyz
bacteri
cultur
qpcr
equi
group
six
replic
result
singl
posit
bacteri
cultur
detect
group
regard
qpcr
sampl
group
posit
wherea
group
b
c
respect
posit
conclus
disinfect
method
elimin
live
equi
none
includ
commerci
endoscop
washer
ensur
complet
remov
equi
dna
detect
qpcr
thu
risk
retent
live
equi
follow
endoscop
clean
appear
low
even
machin
wash
instrument
contribut
fals
posit
qpcr
screen
hors
strangl
method
live
cultur
strep
equi
inocul
onto
variou
site
equip
compris
outdoor
fenc
post
piec
plain
wood
indoor
sole
shoe
cotton
overal
insid
nasogastr
tube
dental
rasp
bottom
wet
plastic
bucket
repeat
sampl
site
conduct
follow
attempt
cultur
strep
equi
collect
sampl
studi
perform
initi
summer
repeat
winter
result
longest
record
surviv
time
day
wet
bucket
winter
surviv
record
beyond
day
summer
stomach
tube
discuss
maximum
bacteri
surviv
time
growth
score
vari
markedli
depend
inocul
site
time
year
bacteri
surviv
clearli
favour
wet
environ
winter
conclus
studi
confirm
strep
equi
gener
fragil
organ
surviv
well
outsid
hors
howev
given
protect
wet
cold
condit
potenti
prolong
environment
surviv
possibl
contagion
suscept
hors
signific
disinfect
protocol
follow
strangl
outbreak
particularli
vigil
toward
wet
site
especi
cold
weather
key
word
strangl
environ
surviv
streptococcu
equi
object
equin
atyp
myopathi
caus
consumpt
seedl
acer
pseudoplatanu
sycamor
tree
widespread
pastur
europ
howev
optim
pastur
manag
avoid
toxic
unclear
evalu
effect
mow
herbicid
spray
hypoglycin
hga
concentr
die
sycamor
seedl
method
seedl
locat
assign
group
mow
n
herbicid
dimethylamin
treatment
n
seedl
collect
intervent
hour
week
later
mow
seedl
cut
midstem
length
surround
grass
left
pastur
seedl
herbicid
experi
spray
accord
manufactur
instruct
left
wither
hga
concentr
measur
valid
lcm
method
express
dri
matter
basi
result
signific
differ
hga
concentr
time
point
either
group
hga
concentr
remain
high
ugg
median
rang
hga
concentr
increas
significantli
grass
cut
undetect
time
zero
ugg
mean
p
week
mow
group
discuss
conclus
neither
mow
herbicid
spray
reduc
hga
concentr
sycamor
seedl
week
intervent
cross
contamin
possibl
grass
sycamor
seedl
mow
togeth
signific
mow
collect
sycamor
seedl
seem
necessari
avoid
possibl
hga
toxic
hors
graze
pastur
contamin
sycamor
seedl
seedl
andor
grass
cut
affect
pastur
fed
hors
even
dri
spray
herbicid
key
word
atyp
myopathi
hypoglycin
pastur
manag
seedl
cooximetri
gold
standard
method
measur
hemoglobin
speci
use
determin
oxygen
statu
differ
speci
purpos
studi
determin
effect
time
sampl
cooximetri
measur
equin
blood
sampl
effect
ad
ascorb
acid
methylen
blue
sampl
invitro
induc
methemoglobinemia
total
healthi
hors
sampl
cooximetri
measur
repeatedli
venou
arteri
blood
sampl
store
ice
water
hour
sampl
sodium
nitrit
ad
blood
sampl
produc
methemoglobin
six
sampl
use
control
ascorb
acid
ascac
ad
methylen
blue
metblu
ad
paramet
measur
includ
total
hemoglobin
tothb
oxyhemoglobin
hbo
carboxyhemoglobin
co
hb
metahemoglobin
methb
oxygen
carri
capac
cap
oxygen
content
ct
oxygen
satur
hemoglobin
oxyhemoglobin
increas
time
respect
hour
mean
sd
p
effect
treatment
p
time
interact
p
methb
sampl
methb
rang
time
chang
methb
follow
hour
control
ascac
metblu
group
respect
p
effect
time
methb
ascac
group
time
hour
storag
blood
ice
water
determin
hbo
use
cooximet
exceed
hour
measur
methb
could
delay
hour
ascorb
acid
ad
sampl
methylen
blue
significantli
decreas
methb
time
compar
untreat
control
sampl
key
word
blood
gase
carboxyhemoglobin
dyshemoglobinemia
methemoglobinemia
reduc
hemoglobin
object
circul
cellfre
mirna
propos
new
promis
class
cancer
biomark
due
high
stabil
plasma
serum
goal
studi
identifi
equin
sarcoid
es
diseasespecif
serum
profil
method
casecontrol
studi
conduct
identifi
differ
serum
mirna
express
profil
esaffect
control
hors
use
high
throughput
sequenc
illumina
result
differenti
express
mirna
identifi
adjust
pvalu
fold
chang
either
direct
mirna
upregul
mirna
downregul
serum
eshors
among
significantli
deregul
mirna
novel
equin
mirna
famili
discuss
despit
obviou
potenti
diseas
biomark
still
common
opinion
regard
biolog
function
circul
extracellular
mirna
studi
suggest
abil
manipul
tumor
environ
order
make
permiss
tumor
growth
invas
top
known
differenti
regul
mirna
analyz
mirpath
tool
union
predict
experiment
valid
target
show
enrich
pathway
involv
cancer
transcript
misregul
cancer
conclus
serum
mirna
express
profil
differ
es
affect
control
hors
role
circul
mirna
molecular
pathway
equin
sarcoid
need
investig
signific
noninvas
diagnosi
es
diseas
may
possibl
identif
mirna
fingerprint
serum
key
word
biomark
equin
oncolog
equin
sarcoid
mirna
object
inhal
immunostimulatori
bacteri
dna
segment
cytosinephosphateguanosineoligodeoxynucleotid
cpgodn
shown
normal
clinic
cytolog
paramet
sever
equin
asthma
recurr
airway
obstruct
rao
hypothes
cpgodn
inhal
reduc
misbal
elastinolyt
activ
hors
affect
rao
method
hors
diagnos
rao
clinic
examin
use
score
system
includ
hors
treat
inhal
cpgodn
day
interv
matrixmetalloproteinas
tissu
inhibitor
metalloproteinas
concentr
measur
tracheal
aspir
use
equin
elisa
kit
uscn
life
scienc
inc
immedi
week
cpgodn
inhal
result
mmp
timp
concentr
correl
result
clinic
score
stage
equin
asthma
inhal
therapi
led
signific
reduct
clinic
score
concentr
reduc
significantli
immedi
mmp
timp
concentr
week
therapi
discuss
equin
asthma
overexpress
mmp
contribut
patholog
tissu
destruct
timp
counteract
mmp
overexpress
lead
fibrosi
format
result
studi
show
cpgodn
inhal
effect
therapi
address
misbal
equin
asthma
conclus
misbal
elastinolyt
activ
posit
influenc
cpgodn
inhal
least
post
therapi
may
reduc
remodel
extracellular
matrix
studi
evalu
effect
comparison
glucocorticoid
inhal
therapi
signific
cpgodn
inhal
may
effect
therapi
prevent
pulmonari
fibrosi
format
equin
asthma
key
word
cpgodn
equin
asthma
hors
inhal
mmp
rao
respiratori
timp
object
studi
effect
tt
evalu
thoroughbr
standardbr
racehors
prospect
crossov
blind
clinic
studi
method
thoroughbr
standardbr
racehors
examin
use
overground
endoscopi
fullintens
exercis
train
race
track
without
fixat
tongu
use
tt
equival
exercis
intens
ensur
measur
heart
rate
bpm
speed
gp
venou
lactat
pharyng
diamet
express
pharyngealepiglottisratio
describ
former
studi
laryng
abduct
accordingli
laryngealmedianratio
result
pharyng
diamet
increas
significantli
hors
rest
fullintens
exercis
p
multivariableanalysi
reveal
effect
significantli
decreas
applic
tongu
tie
p
signific
effect
tt
laryng
paramet
found
ddsp
found
examin
tt
examin
without
tt
discuss
contradictori
publish
evid
potenti
efficaci
tongu
tie
tt
upper
airway
function
treatment
intermitt
dorsal
displac
soft
palat
ddsp
racehors
posit
effect
pharyng
laryng
diamet
found
studi
studi
focu
anim
welfar
conclus
result
studi
support
use
tt
support
upper
airway
function
prevent
occurr
ddsp
signific
result
studi
might
provid
object
evid
futur
decis
equin
sport
organ
concern
regul
tt
key
word
ddsp
overground
endoscopi
tongu
tie
object
determin
whether
high
qualiti
hour
continu
ambulatori
telemetr
eeg
record
made
use
prefab
horsecap
secondli
determin
whether
record
help
determin
sub
clinic
epilept
patholog
method
ambulatori
telemetr
electroencephalogram
record
adult
control
hors
adult
patient
abnorm
behaviour
unknown
origin
epilepticlik
insult
absenc
extra
cranial
diseas
eegcap
develop
hors
amplifi
record
softwar
lifelin
use
commerci
video
camera
connect
record
laptop
analysi
sensit
set
microvoltcm
timebas
spage
start
point
lowcut
filter
set
hz
highcut
hz
notch
filter
hz
abnorm
activ
defin
spike
sharp
wave
period
gener
slow
wave
rhythmic
activ
gener
fast
rhythmic
discharg
record
time
rang
hour
result
clinic
technic
problem
record
good
qualiti
one
control
hors
show
abnorm
brain
activ
six
patient
show
abnorm
brain
activ
simultan
video
surveil
prove
essenti
recogn
artefact
due
ear
lip
eye
movement
shake
headrub
conclus
clinic
relev
use
horsecap
facilit
applic
process
result
good
qualiti
record
telemetr
ambulatori
eeg
use
simultan
video
record
help
asset
neurolog
diagnost
workup
object
determin
whether
hors
treat
corticosteroid
increas
risk
lamin
whether
associ
corticosteroid
type
method
retrospect
casecontrol
studi
undertaken
hors
treat
corticosteroid
royal
veterinari
colleg
equin
first
opinion
practic
referr
hospit
includ
case
one
timematch
control
seen
veterinarian
treat
corticosteroid
identifi
preval
lamin
compar
group
associ
corticosteroid
type
assess
result
case
develop
lamin
within
day
corticosteroid
therapi
control
develop
lamin
within
time
period
neither
two
case
develop
lamin
relev
lamin
risk
factor
howev
control
histori
previou
lamin
one
underli
endocrinopathi
associ
lamin
occurr
type
corticosteroid
prescrib
discuss
perceiv
risk
lamin
associ
medium
longterm
corticosteroid
prepar
greater
associ
shortterm
prepar
report
lamin
follow
use
corticosteroid
oral
prednisolon
limit
case
report
first
casecontrol
studi
evalu
risk
conclus
use
variou
corticosteroid
prepar
includ
oral
perdnisolon
methylprednisolon
triamcinolon
intraven
oral
dexamethason
inhal
corticosteroid
associ
increas
preval
lamin
signific
administr
corticosteroid
increas
preval
lamin
object
studi
aim
valid
clinic
score
system
could
use
practition
improv
detect
acutesubacut
eg
case
field
base
simpl
epidemiolog
clinic
variabl
method
two
studi
perform
creat
valid
score
system
suspect
eg
case
group
roc
curv
creat
area
roc
curv
calcul
cutoff
score
highest
sensit
group
select
use
cutoff
score
calcul
group
rang
score
determin
tri
discrimin
probabl
suspect
neg
case
result
clinic
score
greater
would
make
anim
highli
probabl
posit
eg
case
score
would
make
anim
suspect
case
score
less
would
unlik
eg
rang
score
system
sensit
specif
anim
would
correctli
classifi
discuss
premortem
diagnosi
eg
challeng
definit
diagnosi
requir
laparotomylaparoscopyassist
ilealmyenter
lymph
node
biopsi
need
improv
detect
diseas
countri
like
franc
incid
unknown
presum
low
conclus
score
develop
repres
inexpens
use
tool
identif
suspect
eg
case
field
situat
signific
score
easi
calcul
could
help
field
veterinarian
easili
identifi
potenti
case
eg
key
word
dysautonomia
equin
grass
sick
analysi
outcom
complic
larg
intestin
transabdomin
transrect
trocharis
hors
hors
angelika
schoster
nicol
altermatt
andrea
bischofberg
equin
depart
univers
zurich
zurich
switzerland
swiss
institut
equin
medicin
univers
bern
agroscop
bern
switzerland
object
describ
outcom
trocharis
identifi
factor
associ
occurr
periton
method
hors
colic
underw
percutan
tran
rectal
trocharis
includ
odd
ratio
chi
squar
test
use
identifi
factor
associ
outcom
occurr
periton
cellsl
factor
evalu
site
number
trocharis
presenc
ping
auscult
ga
distens
rectal
examin
complic
procedur
roll
gener
anesthesia
clinic
sign
periton
defin
anorexia
lethargi
fever
abnorm
mucu
membran
hyperfibrinogenemia
leukocytosi
result
one
four
trocharis
perform
per
hors
transabdomin
transrect
medic
treat
hors
surviv
none
euthan
relat
trocharis
hors
three
procedur
like
euthan
compar
one
ci
p
hors
undergo
procedur
like
euthan
compar
sole
transabdomin
trocharis
p
periton
present
none
factor
test
associ
occurr
periton
clinic
sign
periton
present
hors
roll
gener
anesthesia
follow
trocharis
discuss
periton
common
clinic
sign
associ
uncommon
roll
trocharis
result
clinic
relev
periton
signific
trocharis
safe
procedur
hors
clinic
sign
periton
rare
howev
higher
complic
rate
anticip
roll
hors
trocharis
coastal
bermuda
hay
strongli
associ
ileal
impact
southeastern
unit
state
stabl
flax
bed
anecdot
associ
condit
europ
aim
studi
investig
associ
ileal
impact
use
flax
shive
oppos
straw
bed
medic
record
referr
case
evalu
abdomin
pain
januari
may
review
diagnosi
date
admiss
age
breed
gender
weight
stall
bed
outcom
record
associ
bed
ileal
impact
evalu
chi
squar
test
odd
ratio
confid
interv
ci
calcul
proport
case
stabl
flax
bed
overal
preval
ileal
impact
flax
group
preval
ileal
impact
oppos
straw
group
ci
p
indic
hors
stabl
flax
bed
approxim
time
like
ileal
impact
compar
hors
stabl
straw
signific
associ
date
admiss
age
breed
gender
weight
found
multivari
model
surviv
discharg
medic
treat
group
compar
surgic
treat
group
signific
associ
found
surviv
discharg
type
bed
result
suggest
hors
hous
flax
bed
like
develop
ileal
impact
compar
hors
straw
object
recent
show
moderatesever
equin
glandular
gastric
diseas
eggd
associ
exagger
cortisol
releas
follow
acth
stimul
aim
present
studi
determin
best
time
point
salivari
cortisol
measur
stimul
method
twentysix
endur
event
hors
sport
hors
without
clinic
complaint
independ
popul
patient
patient
p
group
gastroscop
find
nomild
vs
moderatesever
eggd
grade
vs
equin
squamou
gastric
diseas
esgd
respect
underw
acth
stimul
test
salivari
cortisol
analyz
minut
intraven
inject
ugkg
synthet
synacthen
novarti
receiveroperatingcharacterist
roc
analys
time
point
auc
correct
baselin
perform
result
salivari
cortisol
valu
minut
acth
inject
show
best
agreement
moderatesever
eggd
base
sensit
p
specif
p
pvalu
p
p
comparison
auc
show
inferior
sensit
p
specif
p
pvalu
p
p
p
signific
associ
esgd
discuss
initi
releas
cortisol
rather
peak
total
increas
auc
appear
relev
regard
eggd
conclus
salivari
cortisol
measur
minut
acth
administr
show
best
perform
diagnost
accuraci
present
support
clinic
use
signific
character
adren
respons
acth
stimulu
may
improv
understand
eggd
pathophysiolog
relat
stress
key
word
acth
challeng
gastric
ulcer
stress
aortic
regurgit
ar
mitral
regurgit
mr
common
hors
purpos
studi
investig
noninvas
measur
puls
pressur
pp
hors
ar
mr
propos
pp
cutoff
valu
identifi
ar
assess
sever
ar
medic
record
hors
present
april
june
cardiac
examin
retrospect
analyz
hors
arrhythmia
chronic
heart
failur
unclear
primari
diagnosi
age
kg
bodyweight
exclud
hors
noninvas
blood
pressur
record
averag
measur
medtron
lifepak
diagnos
diseas
sever
confirm
echocardiographi
case
categor
base
primari
diagnosi
ar
n
mr
n
healthi
control
n
regurgit
sever
mild
moder
sever
colorflow
map
pp
compar
group
use
oneway
anova
cutoff
valu
determin
roc
analysi
pp
significantli
increas
ar
compar
mr
mean
differ
ci
mmhg
control
mmhg
sensit
sn
specif
sp
likelihood
ratio
lr
pp
distinguish
ar
mr
control
cutoff
mmhg
cutoff
mmhg
sn
sp
lr
differenti
sever
mildmoder
ar
cutoff
mmhg
cutoff
mmhg
respect
conclus
pp
increas
hors
ar
noninvas
pp
measur
aid
clinician
stage
sever
ar
hors
key
word
aortic
regurgit
noninvas
blood
pressur
puls
pressur
